Sangamo Therapeutics, Inc. Stock
Stocks
SGMOQ
US8006771062
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
15:48:04 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 0.1102 USD | -21.79% |
|
-25.43% | -73.76% |
| Market Cap | 45.65M 40.58M 37.61M 34.22M 64.58M 4.33B 65.61M 452M 177M 2.26B 171M 168M 7.21B | P/E 2024 |
-2.1x | P/E 2025 | -0.96x |
|---|---|---|---|---|---|
| Enterprise Value | 51.5M 45.78M 42.43M 38.61M 72.85M 4.89B 74.02M 510M 200M 2.55B 193M 189M 8.13B | EV / Sales 2024 |
3.49x | EV / Sales 2025 | 3.72x |
| Free-Float |
99.07% | Yield 2024 * |
-
| Yield 2025 | - |
| Markets | Quality | ||
|---|---|---|---|
OTC Markets
| SGMOQ | Delayed | |
London S.E.
| 0R1D | Delayed |
Last Transcript: Sangamo Therapeutics, Inc.
| 1 day | -21.79% | ||
| 1 week | -25.43% | ||
| Current month | -25.03% | ||
| 1 month | -23.95% | ||
| 3 months | +69.54% | ||
| 6 months | -57.94% | ||
| Current year | -73.76% |
| 1 week | 0.01 | 0.15 | |
| 1 month | 0.01 | 0.16 | |
| Current year | 0.01 | 0.6 | |
| 1 year | 0.01 | 0.69 | |
| 3 years | 0.01 | 3.18 | |
| 5 years | 0.01 | 11.49 | |
| 10 years | 0.01 | 27.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alexander Macrae
CEO | Chief Executive Officer | 63 | 2016-05-31 |
Nikunj Jain
DFI | Director of Finance/CFO | 47 | 2026-02-02 |
Phillip Ramsey
CTO | Chief Tech/Sci/R&D Officer | - | 2023-05-28 |
| Director | Title | Age | Since |
|---|---|---|---|
H. Parker
CHM | Chairman | 70 | 2017-05-31 |
Alexander Macrae
BRD | Director/Board Member | 63 | 2016-05-31 |
Robert Carey
BRD | Director/Board Member | 68 | 2016-05-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/25/26 | Tax | General Counsel | -4,036 | 0.0010% | ||
| 5/25/26 | Tax | Executive/Senior Manager | -4,036 | 0.0010% | ||
| 5/25/26 | Tax | Chief Executive Officer | -12,613 | 0.0030% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -21.79% | -25.43% | -82.76% | -79.44% | 45.65M | ||
| -6.60% | -8.56% | +49.38% | +64.90% | 65B | ||
| +0.26% | +5.30% | +9.29% | +76.73% | 51.2B | ||
| +0.44% | -0.33% | +0.11% | +62.11% | 51.19B | ||
| -1.53% | +2.70% | +30.48% | +41.25% | 43.93B | ||
| -1.34% | +4.12% | +16.64% | +120.28% | 41.96B | ||
| -5.97% | -6.22% | +228.95% | +483.48% | 38.14B | ||
| +6.53% | +8.02% | +16.40% | +56.32% | 33.24B | ||
| -0.90% | -10.49% | +37.09% | +1.80% | 25.2B | ||
| -0.80% | -0.28% | +24.84% | +24.87% | 22.5B | ||
| Average | -3.17% | -2.86% | +33.04% | +85.23% | 37.24B | |
| Weighted average by Cap. | -1.53% | -0.50% | +44.29% | +104.99% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 57.8M 51.38M 47.62M 43.33M 81.76M 5.49B 83.07M 572M 224M 2.86B 217M 212M 9.13B | 39.55M 35.16M 32.59M 29.65M 55.95M 3.75B 56.84M 392M 154M 1.96B 148M 145M 6.24B |
| Net income | -97.94M -87.06M -80.69M -73.42M -139M -9.3B -141M -970M -380M -4.85B -368M -360M -15.46B | -123M -109M -101M -92.15M -174M -11.67B -177M -1.22B -477M -6.09B -461M -452M -19.41B |
| Net Debt | -11.35M -10.09M -9.35M -8.51M -16.06M -1.08B -16.32M -112M -44.08M -562M -42.6M -41.7M -1.79B | 5.85M 5.2M 4.82M 4.38M 8.27M 555M 8.4M 57.91M 22.7M 290M 21.94M 21.48M 923M |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-16 | US$0.1102 | -21.79% | 1,967,535 |
| 26-10-15 | US$0.1409 | +0.71% | 3,569,256 |
| 26-10-14 | US$0.1399 | -0.14% | 3,471,665 |
| 26-10-13 | US$0.1401 | -6.60% | 818,448 |
| 26-10-12 | US$0.1500 | +1.50% | 1,059,984 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SGMOQ Stock
Select your edition
All financial news and data tailored to specific country editions

















